Expand CLDX Menu
CLDX MENU

CLDX Latest Press Releases

-- October 12, 2026 --

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Celldex Therapeutics, Inc. (NASDAQ: CLDX) PRNewswire 9:10 AM

-- September 22, 2026 --

Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints Globe Newswire 6:58 AM

-- September 8, 2026 --

Celldex to Present at Upcoming Investor Conference Globe Newswire 4:01 PM

-- August 24, 2026 --

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Celldex Therapeutics, Inc. (NASDAQ: CLDX) PRNewswire 8:45 AM

-- August 6, 2026 --

Celldex Reports Second Quarter Financial Results and Provides Corporate Update Globe Newswire 4:01 PM

-- July 21, 2026 --

Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis Globe Newswire 4:01 PM

-- July 15, 2026 --

Celldex Announces Planned Transition of Chief Financial Officer Globe Newswire 4:01 PM

-- June 14, 2026 --

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Globe Newswire 10:21 AM
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Globe Newswire 5:15 AM

-- June 10, 2026 --

Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress Globe Newswire 4:01 PM
Market Data Delayed 15 Minutes